GoodRx Holdings Inc.

10/01/2024 | Press release | Distributed by Public on 10/01/2024 12:00

Kerendia vs. Jardiance: 5 Differences Between These Kidney Disease Medications

Key takeaways:

  • Kerendia (finerenone) and Jardiance (empagliflozin) are two medications that can help prevent chronic kidney disease (CKD) from getting worse.

  • Kerendia is FDA approved for adults living with CKD that's associated with Type 2 diabetes. Jardiance is approved to prevent CKD from getting worse in adults regardless of whether they have diabetes. The medications work in different ways to help protect the kidneys from damage.

  • Your prescriber can let you know whether Kerendia or Jardiance would be a better option for you. But the two medications can be safely combined if needed.

  • There are ways to save on Kerendia and Jardiance. If you're eligible, manufacturer savings cards can help make your prescription more affordable. Patient assistance programs are also available.

Access savings on related medications

info_outlinedPromotional disclosure
FG Trade Latin/E+ via Getty Images

Over the past decade, there have been significant advancements when it comes to managing chronic kidney disease (CKD). Notably, a few new medications have been FDA approved for people with the condition. These medications not only help prevent kidney function from worsening, but also lower the risk of life-threatening complications related to CKD.

Kerendia (finerenone) and Jardiance (empagliflozin) are two medications that can provide these benefits for certain people living with CKD. And they're both recommended by experts to help lower the risk of CKD complications.

But are Jardiance and Kerendia the same types of medications? The short answer is no. These medications work differently and have distinct uses. Below, we review five differences to keep in mind when comparing Kerendia versus Jardiance for CKD.

EXPERT PICKS: WHAT TO READ NEXT

1. Kerendia and Jardiance have different FDA-approved uses

One main difference between Kerendia and Jardiance is their FDA-approved uses. This may be a main deciding factor for your prescriber when they're considering whether to recommend one over the other.

Kerendia is FDA approved to lower the risk of worsening kidney function, cardiovascular complications or death, and hospitalization for heart failure for adults living with CKD that's associated with Type 2 diabetes. Kerendia isn't approved for use in people who don't have Type 2 diabetes.

Jardiance has a few different FDA-approved uses. It's approved for:

  • Lowering the risk of worsening kidney function, hospitalization, and cardiovascular death for adults living with CKD (whether or not they have diabetes)

  • Lowering the risk of hospitalization and cardiovascular death for adults living with heart failure (whether or not they have diabetes)

  • Lowering blood glucose (sugar) levels along with a diabetes-friendly diet and regular exercise in adults and children age 10 and older living with Type 2 diabetes

  • Lowering the risk of cardiovascular death in adults living with Type 2 diabetes and heart disease

2. Kerendia and Jardiance work differently in the body

Kerendia and Jardiance work in different ways to manage CKD.

Kerendia is a nonsteroidal mineralocorticoid receptor antagonist (MRA). It works by blocking the activity of the hormone aldosterone in the kidneys, heart, and blood vessels. Some amount of aldosterone is necessary to help regulate blood pressure and sodium levels in the body. But some people with CKD have higher levels of aldosterone than people who don't have the condition.

High levels of aldosterone can cause inflammation and scarring of the kidneys, heart, and blood vessels. Over time, this can damage these parts of the body. By blocking aldosterone's activity, Kerendia can help prevent or slow aldosterone's harmful effects.

Jardiance is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. It primarily works by blocking the protein SGLT2 in the kidneys. This helps remove excess glucose and sodium from the bloodstream. Less sodium, in particular, helps take strain off the kidneys and heart.

Experts believe Jardiance helps protect the kidneys in other ways, too. These include lowering blood pressure, helping the kidneys to work more efficiently, and preventing kidney inflammation and scarring.

3. Kerendia and Jardiance have different typical dosages

Both Kerendia and Jardiance are available as oral tablets. But there are differences in how the medications are taken.

The target Kerendia dosage for most people is 20 mg by mouth once a day. But your dosage may be lower than that depending on your kidney function and blood potassium levels. You can take Kerendia at any time of day. But for consistent effects, you should take your dose at about the same time each day.

The typical Jardiance dosage for CKD is 10 mg by mouth once a day. You should take your doses in the morning. As we'll discuss more below, Jardiance can cause you to pee more in the hours after you take it. So taking it in the morning can help you avoid waking up throughout the night to use the bathroom.

There aren't any recommended dosage adjustments if you're only taking Jardiance for CKD. If you also have Type 2 diabetes, your prescriber may raise your dosage to 25 mg once a day if the lower dosage isn't keeping your glucose levels in your target range.

Good to know: If you have trouble swallowing pills, you can crush Kerendia tablets and mix them with water or soft foods like applesauce right before taking your doses. You shouldn't cut, chew, or crush Jardiance tablets.

4. Kerendia and Jardiance have different side effects

Potential side effects are another difference to consider when comparing Kerendia and Jardiance. Common and mild side effects for each medication are listed in the table below.

Kerendia side effects

Jardiance side effects

• Lower blood pressure

• Raised potassium levels

• Lower sodium levels

• Peeing more than usual

• Urinary tract infections (UTIs)

• Genital fungal ("yeast") infections

• Upper respiratory infections

• Nausea

• Joint pain

• Raised cholesterol

• Moderate weight loss for some people

While raised potassium levels (hyperkalemia) with Kerendia is common, it can become harmful or even dangerous in some cases. If your potassium is too high, you may experience symptoms such as muscle weakness, nausea or vomiting, or fatigue. In severe cases, potentially life-threatening arrhythmias (irregular heartbeats) can also occur. Because of this, you'll need to go for routine blood work to make sure your potassium levels are staying within a safe range.

Jardiance also has a few serious side effects to know about. In severe cases, Jardiance may cause dehydration because of increased urination. The medication can also cause hypoglycemia (low blood glucose) and, in very rare cases, ketoacidosis (too much acid in the blood). Life-threatening infections are also possible, but very rare.

Certain health conditions and interacting medications may raise your risk of serious side effects related to Kerendia or Jardiance. This is not a comprehensive list of all the possible side effects for either medication. Your prescriber can help weigh the pros and cons of each to determine which might be right for you.

5. Kerendia and Jardiance have different potential interactions

Potential drug interactions can be a major factor when it comes to choosing between Kerendia and Jardiance. These two medications have unique sets of potential interactions.

Many of Kerendia's interactions raise the risk of experiencing high potassium levels. Notable Kerendia interactions can be caused by:

  • Grapefruit juice

  • St. John's wort (an herbal supplement)

  • Amiodarone (Pacerone)

  • Medications that raise potassium levels, such as spironolactone (Aldactone)

  • Angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril (Zestril, Qbrelis)

  • Angiotensin II receptor blockers (ARBs), such as losartan (Cozaar)

  • Some antibiotics, such as ciprofloxacin (Cipro) and erythromycin (Ery-Tab)

  • Medications that contain ritonavir (Norvir), such as Paxlovid (nirmatrelvir / ritonavir)

  • Certain calcium channel blockers, such as diltiazem (Cardizem) and verapamil

  • Certain seizure medications, such as carbamazepine and phenytoin (Dilantin, Phenytek)

Many of Jardiance's interactions raise the risk of dehydration or hypoglycemia. Notable Jardiance interactions can be caused by:

  • Diuretics (water pills), such as hydrochlorothiazide (Microzide) and furosemide (Lasix)

  • Insulin

  • Sulfonylureas, such as glipizide (Glucotrol XL) and glyburide (Glynase, DiaBeta)

  • Meglitinides ("glinides"), such as repaglinide

  • Lithium (Lithobid)

In many cases, Kerendia and Jardiance interactions can be managed with dosage changes. Be sure to share an updated medication list with your prescriber and pharmacist when starting treatment with either Kerendia or Jardiance. They can use this list to identify and manage potential interactions.

Can you take Kerendia and Jardiance together?

Yes, you can safely combine Kerendia and Jardiance if needed. In fact, there's evidence that taking both, along with an ACE inhibitor or an ARB, may help lower your risk of serious CKD complications more than taking just one or two of these medications. So it's possible that your prescriber may recommend taking both Kerendia and Jardiance.

How to save on Kerendia and Jardiance

There are ways to save on Kerendia and Jardiance, which are only available as brand-name medications. GoodRx can help you navigate between patient assistance programs and copay savings cards:

  • Save with a copay savings card. If you have commercial insurance, you may be eligible to pay as little as $10 per prescription for Jardiance or as little as $0 per month for Kerendia using a savings card from the manufacturer.

  • Save with a patient assistance program. If you're uninsured or underinsured, you may be eligible for Kerendia's or Jardiance's patient assistance program, which offer the medications free of cost.

The bottom line

Kerendia (finerenone) and Jardiance (empagliflozin) are two medications that can be prescribed to people living with chronic kidney disease (CKD). But Jardiance and Kerendia are not the same types of medications.

Kerendia is FDA approved for adults living with CKD that's associated with Type 2 diabetes. Jardiance is approved for adults living with CKD regardless of whether they have diabetes. Kerendia and Jardiance both work to protect the kidneys, but they do this in different ways. There are also differences between the two medications' side effects and potential interactions.

Your prescriber can help determine which medication might be better for you. But you can safely combine Kerendia and Jardiance if needed for increased kidney protection.

Why trust our experts?

Christina Aungst, PharmD, is a pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019, transitioning from freelance writer to editor in 2021.
Austin Ulrich, PharmD, BCACP, is a board-certified ambulatory care clinical pharmacist. In his early career, he provided direct patient care in a variety of settings, including hospital and community pharmacies, and in a primary care clinic as a clinical pharmacist.

References

Agarwal, R., et al. (2021). Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. European Heart Journal.

Bailey, C. J., et al. (2022). Renal protection with SGLT2 inhibitors: Effects in acute and chronic kidney disease. Current Diabetes Reports.

View All References (5)
expand_more

Bayer Healthcare Pharmaceuticals Inc. (2022). Kerendia - finerenone tablet, film coated [package insert]. DailyMed.

Boehringer Ingelheim Pharmaceuticals, Inc. (2024). Jardiance - empagliflozin tablet, film coated [package insert]. DailyMed.

Minakuchi, H.. et al. (2020). The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: A randomized placebo-controlled clinical trial. Scientific Reports.

Scott, J. H., et al. (2023). Physiology, aldosterone. StatPearls.

Stevens, P. E., et al. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

thumb_up_outlinedthumb_down_outlined
print_outlinedemail_outlined

Get the facts on Chronic Kidney Disease.

Sign up for our newsletter to get expert tips on condition management and prescription savings.
Email address
Subscribe
I would also like to sign up for a free GoodRx account

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.